Healthcare reform will bring new payment models and new power for consumers, and cancer care delivery will not be immune. With that in mind, The American Journal of Managed Care will bring together experts from the front lines to Baltimore, Maryland, November 14-15 for a conference to share how the goals of better care, savings and fair compensation can be achieved, even in the world of oncology.
Cancer, Managed Care Experts to Lead Talks on How Consumers Will Create Change
FOR IMMEDIATE RELEASE September 9, 2013
PLAINSBORO, N.J. — Healthcare reform will bring new payment models and new power for consumers, and cancer care delivery will not be immune. With that in mind, The American Journal of Managed Care will bring together experts from the front lines — clinical and academic leaders, developers of life-saving therapies, and those who taking healthcare from the old way of doing business to a new one that empowers consumers.
"Patient-Centered Oncology Care: Real World Perspectives” will take place November 14-15 at the Royal Sonesta Harbor Court, Baltimore. This two-day conference, which features an evening networking reception, will bring together key leaders in managed care and beyond. All will share how the goals of better care, savings and fair compensation can be achieved, even in the world of oncology.
Attend this conference if you want to know:
· How cancer care delivery will change under accountable care organizations (ACOs)
· How consumer voices will change the management of cancer care
· How to understand the balance between cost and quality in end-of-life care
· How pharmaceutical companies and insurers can work together
For more information about the conference and a proposed agenda, please visit the web site at: http://www.ajmc.com/meetings/oncologycare13.
Credentialed media who wish to register for the conference must contact Nicole Beagin or Mary Caffrey at (609) 716-7777. A limited number of hotel rooms have been reserved, but members of the media must contact Nicole Beagin to hold a room at the conference rate.
Highlights on major speakers at the conference are attached.
Nicole Beagin (609) 716-7777 x. 131
Mary Caffrey (609) 716-7777 x. 144
Peter B. Bach, MD, MAPP, Memorial Sloan Kettering. Dr. Bach’s interests include healthcare policy, especially alternative Medicare approaches to cancer payment, racial disparities, and coverage policies. He chairs the Technical Expert Panel that is developing measures of cancer care quality for the Centers for Medicare and Medicaid Services (CMS).
Bruce A. Feinberg, DO, Cardinal Health Specialty Solutions. Dr. Feinberg is a leader in specialty oncology and the business of specialty healthcare. With more than 25 years of cancer care experience, he serves as vice president and chief medical officer, oncology, for Cardinal Health Specialty Solutions. His recent paper, published in AJMC’s Evidence-Based Oncology, received widespread attention for showing that cancer care clinical pathways could produce savings across a diverse healthcare network.
Ira M. Klein, MD, MBA, FACP, Aetna, Inc. Dr. Klein is responsible for promoting the strategic efforts of the Office of the Chief Medical Officer, including creating and deploying clinical programs, and facilitating integration and clinician development. He joined Aetna in 2006 and has held various roles in benefit design, financial and clinical analytics, and oncology strategy.
Michael Kolodjiez, MD, Aetna Inc. Dr. Kolodjiez is the national medical director of oncology strategy, Office of the Chief Medical Officer. He served as medical director for Oncology Services for US Oncology for four years, implementing the USON clinical pathways initiative. He was responsible for integration of the USON EMR into this program, and development of the USON disease management and advanced care planning programs.
Lee Newcomer, MD, MHA, UnitedHealthcare. Dr. Newcomer is the senior vice president with responsibility for oncology, genetics and women’s health. Prior to joining UnitedHealthcare, he was a founding executive of Vivius, a consumer directed venture that allowed consumers to create their own personalized health plans. Throughout the 1990s, Dr. Newcomer’s emphasized the development of performance measures and incentives to improve clinical care.